Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-04

Clinical Trial Update: Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on idebenone for Friedreich's ataxia; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Friedreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2011-08-04